Collaborations

Epigenomics inks strategic collaboration in DNA methylation

Published in Gene Therapy Weekly, June 2nd, 2005

Epigenomics, AG, (ECX) and QIAGEN, NV, (QGEN), announced that they have entered into a strategic collaboration to jointly develop and introduce a "gold-standard" preanalytical solution portfolio for DNA methylation analysis.

The jointly developed product portfolio is expected to provide complete and validated preanalytical solutions for use in preclinical research and to have full compatibility for use in in-vitro diagnostics (IVD).

The collaboration will combine Epigenomics' technology in methylation analysis capabilities, including DNA bisulfite treatment, with QIAGEN's preanalytical sample preparation technologies in life sciences and molecular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-06-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry